Ling Zhou

Years Active: 2024-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Ling Zhou, Chengyang Ni, Ruixue Liao, Xiaoqin Tang, Taian Yi, Mei Ran, Miao Huang, Rui Liao, Xiaogang Zhou, Dalian Qin, Long Wang, Feihong Huang, Xiang Xie, Ying Wan, Jiesi Luo, Yiwei Wang, Jian-Ming Wu
Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia. eLife 13 (2024)
Ling Zhou, Chengyang Ni, Ruixue Liao, Xiaoqin Tang, Taian Yi, Mei Ran, Miao Huang, Rui Liao, Xiaogang Zhou, Dalian Qin, Long Wang, Feihong Huang, Xiang Xie, Ying Wan, Jiesi Luo, Yiwei Wang, Jian-Ming Wu
Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia. eLife 13 (2024)
Ling Zhou, Chengyang Ni, Ruixue Liao, Xiaoqin Tang, Taian Yi, Mei Ran, Miao Huang, Rui Liao, Xiaogang Zhou, Dalian Qin, Long Wang, Feihong Huang, Xiang Xie, Ying Wan, Jiesi Luo, Yiwei Wang, Jian-Ming Wu
Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia. eLife 13 (2024)

Ling Zhou.css-eqlu8i{font-size:small;padding-left:4px;}